Center for Scientific Review; Notice of Closed Meetings, 43863 [2020-15547]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 139 / Monday, July 20, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institutes of Health
[Docket No. DHS–2020–0002]
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neuropsychiatric Disorders.
Date: August 7, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jenny Raye Browning,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 5207,
Bethesda, MD 20892, (301) 402–8197,
jenny.browning@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and Related Research.
Date: August 11, 2020.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Nitsa Rosenzweig, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7760, Bethesda, MD 20892, (301) 404–
7419, rosenzweign@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 14, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–15547 Filed 7–17–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:30 Jul 17, 2020
Jkt 250001
Notice of Request for Extension of a
Currently Approved Information
Collection for Chemical-Terrorism
Vulnerability Information (CVI)
Cybersecurity and
Infrastructure Security Agency, DHS.
ACTION: 30-Day notice and request for
comments; extension of Information
Collection Request: 1670–0015.
AGENCY:
The Infrastructure Security
Division (ISD) within the Cybersecurity
and Infrastructure Security Agency
(CISA) will submit the following
Information Collection Request (ICR) to
the Office of Management and Budget
(OMB) for review and clearance in
accordance with the Paperwork
Reduction Act of 1995. CISA previously
published a notice about this ICR, in the
Federal Register on March 30, 2020, for
a 60-day comment period. 85 FR
17953.1 There were no comments
received. In this notice, CISA solicits
additional public comment concerning
this ICR for 30-days in accordance with
5 CFR 1320.8.
DATES: Comments are due by August 19,
2020.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, OMB. Comments should be
addressed to OMB Desk Officer,
Department of Homeland Security,
Cybersecurity and Infrastructure
Security Agency, and sent via electronic
mail to dhsdeskofficer@omb.eop.gov.
All submissions must include the words
‘‘Department of Homeland Security’’
and the OMB Control Number 1670–
0015.
Comments submitted in response to
this notice may be made available to the
public through relevant websites. For
this reason, please do not include in
your comments information of a
confidential nature, such as sensitive
personal information or proprietary
information. Please note that responses
to this public comment request
containing any routine notice about the
confidentiality of the communication
will be treated as public comments that
may be made available to the public
notwithstanding the inclusion of the
routine notice.
Comments that include trade secrets,
confidential commercial or financial
information, Chemical-terrorism
SUMMARY:
1 The 60-day notice may be viewed at https://
www.federalregister.gov/d/2020-06499.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
43863
Vulnerability Information (CVI),2
Sensitive Security Information (SSI),3 or
Protected Critical Infrastructure
Information (PCII) 4 should not be
submitted to the public docket.
Comments containing trade secrets,
confidential commercial or financial
information, CVI, SSI, or PCII should be
appropriately marked and packaged in
accordance with applicable
requirements and submitted by mail to
the DHS/CISA/Infrastructure Security
Division, CFATS Program Manager, 245
Murray Lane SW, Mail Stop 0610,
Arlington, VA 20528–0610. The
Department will forward all comments
received by the submission deadline to
the OMB Desk Officer.
FOR FURTHER INFORMATION CONTACT:
Lona Saccomando, 703–235–5263,
CISARegulations@cisa.dhs.gov.
The
CFATS Program identifies and regulates
the security of high-risk chemical
facilities using a risk-based approach.
Congress initially authorized the CFATS
Program under Section 550 of the
Department of Homeland Security
Appropriations Act of 2007, Public Law
109–295 (2006) and reauthorized it
under the Protecting and Securing
Chemical Facilities from Terrorist
Attacks Act of 2014 5 or ‘‘CFATS Act of
2014’’. The Department implemented
the CFATS Program through rulemaking
and issued an Interim Final Rule (IFR)
on April 9, 2007 and a final rule on
November 20, 2007. See 72 FR 17688
and 72 FR 65396.
Pursuant to 6 U.S.C. 623, the CFATS
regulations establish the requirements
under 6 CFR 27.400 that covered
persons must follow to safeguard certain
documents and other information
developed under the regulations from
unauthorized disclosure. This
information is identified as CVI and, by
law, receives protection from public
disclosure and misuse. This collection
will be used to manage the CVI program
in support of CFATS. The current
information collection for the CVI
SUPPLEMENTARY INFORMATION:
2 For more information about CVI see 6 CFR
27.400 and the CVI Procedural Manual at
www.dhs.gov/publication/safeguarding-cvi-manual.
3 For more information about SSI see 49 CFR part
1520 and the SSI Program web page at www.tsa.gov/
for-industry/sensitive-security-information.
4 For more information about PCII see 6 CFR part
29 and the PCII Program web page atwww.dhs.gov/
pcii-program.
5 The Protecting and Securing Chemical Facilities
from Terrorist Attacks Act of 2014 (also known as
the CFATS Act of 2014, Public Law 113–254)
codified the CFATS program into the Homeland
Security Act of 2002. See 6 U.S.C. 621 et seq., as
amended by Public Law 116–136, Sec. 16007
(2020).
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 85, Number 139 (Monday, July 20, 2020)]
[Notices]
[Page 43863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15547]
[[Page 43863]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neuropsychiatric Disorders.
Date: August 7, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jenny Raye Browning, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 5207, Bethesda, MD 20892, (301)
402-8197, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and Related Research.
Date: August 11, 2020.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nitsa Rosenzweig, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152, MSC 7760, Bethesda, MD
20892, (301) 404-7419, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: July 14, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-15547 Filed 7-17-20; 8:45 am]
BILLING CODE 4140-01-P
